The Metoclopramide Injection, cataloged under National Stock Number 6505-01-649-1070, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Fresenius Kabi, Llc. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BX.
| Parameter | Value |
|---|---|
| NSN | 6505-01-649-1070 |
| Primary Part Number | NDC76045-0101-20 |
| Item Name | Metoclopramide Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Fresenius Kabi, Llc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 24.0 EACH |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | SYRINGE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE AND DO NOT FREEZE AND PROTECT FROM DIRECT SUNLIGHT |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 10.0 MILLIGRAMS METOCLOPRAMIDE PER MILLIGRAM |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BX |
| Part Number | Manufacturer |
|---|---|
| NDC76045-0101-20 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1376696 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM152418 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-649-1070 is a Metoclopramide Injection, manufactured by Fresenius Kabi, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-649-1070 has 1 manufacturer part number on file: NDC76045-0101-20 (Fresenius Kabi, Llc).
Key specifications for NDC76045-0101-20: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 24.0 EACH; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: SYRINGE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.